Dr. John Shillingford brings a wealth of expertise and experience to his role as Director at AureumDX. He holds a BSc in Biochemistry and a PhD in Biochemical Pharmacology from the prestigious University of Surrey.
With over 40 years of experience in the Pharmaceutical and Contract Research industry, John has established himself as a prominent figure in clinical trial design and implementation across Europe and beyond. For the past eight years, he has provided valuable consultancy services to global firms, specialising in the development of clinical drug trials and MedTech devices.
Prior to his consultancy work, John held various senior global roles at Averion International Corporation, where he served as President of Averion GmbH, President of Averion Europe, and Executive Vice President and Global Head of Clinical Operations. He also played vital roles as Managing Director and Vice President of Clinical Operations at Imform Gmbh.